Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 0.000% | 4.575% | 8.108% | 53.846% | -3.614% | 8.108% | -56.757% |
| Northwest Biotherapeutics Inc. | 0.000% | 4.242% | -14.000% | -25.217% | -16.505% | -67.850% | -85.785% |
| Celldex Therapeutics | 0.410% | 4.080% | 10.096% | 63.257% | 29.864% | -13.946% | 13.283% |
News
AI Stock Face-Off: Is Nvidia or AMD the Smarter Long-Term Buy?
Two of the biggest stock winners of the past decade are Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD), which are up over 16,320% and 9,770%, respectively. The two chip rivals have
Marvell Technology Has Trillion-Dollar Potential. Here Is How Soon It Could Arrive.
In the explosive era of artificial intelligence (AI), infrastructure bottlenecks have come to matter just as much as raw compute power. Marvell Technology (NASDAQ: MRVL) is emerging as a key enabler
Will Nvidia Continue to Dominate in AI? This One Number Offers a Strikingly Clear Answer.
Nvidia (NASDAQ: NVDA) has built an artificial intelligence (AI) empire, offering graphics processing units (GPUs) that power essential tasks like the training of AI models and providing a wide range